Literature DB >> 16759714

Characterization of the glycosylphosphatidylinositol anchor of the immunodominant Cryptosporidium parvum 17-kDa antigen.

Jeffrey W Priest1, Angela Mehlert, Delynn M Moss, Michael J Arrowood, Michael A J Ferguson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16759714     DOI： 10.1016/j.molbiopara.2006.04.006

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN： 0166-6851            Impact factor:   1.759


× No keyword cloud information.
  6 in total

1.  Multiplex assay detection of immunoglobulin G antibodies that recognize Giardia intestinalis and Cryptosporidium parvum antigens.

Authors:  Jeffrey W Priest; Delynn M Moss; Govinda S Visvesvara; Cara C Jones; Anna Li; Judith L Isaac-Renton
Journal:  Clin Vaccine Immunol       Date:  2010-09-28

2.  Antibody responses to the immunodominant Cryptosporidium gp15 antigen and gp15 polymorphisms in a case-control study of cryptosporidiosis in children in Bangladesh.

Authors:  Genève M Allison; Kathleen A Rogers; Anoli Borad; Sabeena Ahmed; Mohammad Mahbubul Karim; Anne V Kane; Patricia L Hibberd; Elena N Naumova; Stephen B Calderwood; Edward T Ryan; Wasif A Khan; Honorine D Ward
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

Review 3.  Human immune responses in cryptosporidiosis.

Authors:  Anoli Borad; Honorine Ward
Journal:  Future Microbiol       Date:  2010-03       Impact factor: 3.165

4.  Microarray analysis of the human antibody response to synthetic Cryptosporidium glycopeptides.

Authors:  Jamie Heimburg-Molinaro; Jeffrey W Priest; David Live; Geert-Jan Boons; Xuezheng Song; Richard D Cummings; Jan R Mead
Journal:  Int J Parasitol       Date:  2013-07-12       Impact factor: 3.981

5.  Cloning and characterization of the acidic ribosomal protein P2 of Cryptosporidium parvum, a new 17-kilodalton antigen.

Authors:  Jeffrey W Priest; James P Kwon; Joel M Montgomery; Caryn Bern; Delynn M Moss; Amanda R Freeman; Cara C Jones; Michael J Arrowood; Kimberly Y Won; Patrick J Lammie; Robert H Gilman; Jan R Mead
Journal:  Clin Vaccine Immunol       Date:  2010-04-21

6.  Cryptosporidium parvum vaccine candidates are incompletely modified with O-linked-N-acetylgalactosamine or contain N-terminal N-myristate and S-palmitate.

Authors:  John R Haserick; Joshua A Klein; Catherine E Costello; John Samuelson
Journal:  PLoS One       Date:  2017-08-08       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.